Connect with us

Press Release

TRUSTCO’S UPDATE ON INSURANCE, REAL ESTATE ACQUISITION

Published

on

Windhoek, Khomas, Namibia, 14th Oct 2024 – Trustco Group Holdings Limited (Trustco) has announced updates to its planned purchase of additional shares in Legal Shield Holdings Limited (LSH). Originally announced on April 23, 2024, the transaction involves Trustco acquiring an extra 11.35% stake in LSH from Riskowitz Value Fund LP (RVF). This will increase Trustco’s total ownership of LSH to 91.35%. The transaction, valued at NAD 468 million (USD 27 million), will be completed by issuing new Trustco shares to RVF. The transaction is expected to close by December 31, 2024.

The acquisition includes valuable assets such as Trustco Insurance Limited, Trustco Life Limited, and a large real estate portfolio that includes developments such as Elisenheim Lifestyle Estate, Lafrenz Industrial Park and Herboths. This portfolio consists of 2,473 sellable hectares (6,112 acres) of prime land across Namibia. Since 2011, this real estate has generated more than NAD 934 million (USD 53 million) in cash.

The extensive land bank offers the opportunity to develop more than 26,000 mixed-use plots. Over the past decade, the company has successfully serviced over 1,106 plots across its developments. With a development pipeline extending for the next 25 years, Trustco is well-positioned to address Namibia’s severe shortage of serviced land for residential, commercial, and industrial use.

Quinton Z van Rooyen, Deputy CEO of Trustco

Quinton Z van Rooyen, Deputy CEO of Trustco, commented on the transaction, stating: “This acquisition aligns well with our growth strategy and allows us to take advantage of expected capital growth, improved macroeconomic liquidity, and increased buyer demand in Namibia’s real estate market. By expanding our property portfolio, we’re set to benefit from the country’s recovering property market following the pandemic.”

Van Rooyen further emphasized the increasing interest from international investors, particularly major players in the petroleum and green hydrogen sectors from the U.S. and Europe. “The growing presence of these industry titans in Namibia strengthens our confidence and reaffirms our strategy to expand our real estate holdings. Their investments signal strong prospects for the Namibian economy, creating an ideal environment for Trustco to capitalize on these opportunities,” he added.

Trustco has submitted a circular detailing the transaction to the Johannesburg Stock Exchange (JSE) for review. Once approved, this comprehensive document will be distributed to all shareholders, providing full details on the proposed acquisition.

About Trustco:

Trustco Group Holdings Ltd is an investment entity headquartered in Windhoek, Namibia, which manages a diverse portfolio of investments spanning the insurance, real estate, non-deposit taking financial services, micro-finance, education, and mining sectors. Decisions are biased towards generational investment performance alongside shareholder wealth creation, and short-term hurdles are viewed as catalysts for future growth.

Since inception in 1992, Trustco’s investment portfolio has delivered strong returns with a CAGR of 68.97%, with a well-balanced asset mix, with a current average weighting of 34% in US Dollar based assets, while the remaining 66% is invested in Namibia Dollar (1 NAD = 1 ZAR) based assets. Trustco enjoys the backing of a wide range of coinvestors, including 3 610 from Namibia, 1 443 from abroad, and 94 from institutional entities.

About Namibia:

Namibia is a Southern African country with a population of approximately three million and a GDP per capita of USD 5 031 in 2022. The country is endowed with rich natural resources, with  recent major discoveries of oil and gas reserves, lithium deposits and rare earth minerals that are vital for technology demand globally, with developments also underway in its green hydrogen projects. The Namibian government has heralded these discoveries as a transformative period, holding the potential to double the nation’s GDP by 2040.

The country’s economy expanded by 4.2% in 2023 and is projected to expand by 3.7% in 2024, following a recovery of 5.3% in 2022 from the COVID-19 pandemic. With its wealth of natural resources, pro-business environment, political stability and increasingly skilled workforce, Namibia offers attractive investment prospects across all sectors.

Forward-Looking Statements:

All statements made in this media release with respect to Trustco’s current plans, estimates, strategies beliefs and other statements that are not historical facts, including statements regarding Trustco’s plans to upgrade its ADR program and the results of such an upgrade, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would,” or the negative of these words or other similar terms or expressions. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. The Company may not actually achieve the plans, intentions or expectations disclosed in its forward-looking statements, and you should not place undue reliance on these forward-looking statements. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.

Media Contact

Organization: Trustco Group Holdings

Contact Person: Neville Basson

Website: https://www.tgh.na

Email: Send Email

Contact Number: +264612754501

Address: 2 Keller Street, Trustco House

Address 2: Windhoek

City: Windhoek

State: Khomas

Country: Namibia

Release Id: 14102418438

The post TRUSTCO’S UPDATE ON INSURANCE, REAL ESTATE ACQUISITION appeared on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Dubai Electronic Security Center to Showcase Cybersecurity Initiatives at GISEC 2025 as Official Government Partner

Published

on

  • DESC will highlight its role in advancing Dubai’s cybersecurity ecosystem and strengthening Dubai’s digital infrastructure
  • The Center will showcase strategic initiatives designed to empower the next generation of cybersecurity talent 
  • H.E. Al Shaibani: “We are committed to strengthening the cybersecurity ecosystem and building strategic partnerships across the public and private sectors.”

Dubai, UAE, 3rd May 2025, ZEX PR WIRE, The Dubai Electronic Security Center (DESC) is set to participate as the official government cybersecurity partner for the eighth consecutive year in the 14th edition of the Gulf Information Security Expo and Conference (GISEC Global 2025), taking place from May 6-8 at the Dubai World Trade Centre. 

The Center’s participation in GISEC Global 2025, which gathers over 25,000 cybersecurity professionals representing more than 160 countries, aligns with its strategic objectives aimed at advancing the Dubai Cyber Security Strategy and reinforcing Dubai’s position as one of the world’s digitally safest cities. This participation reflects the Center’s commitment to safeguarding digital infrastructure, fostering innovation, enhancing cyber resilience, and promoting robust cooperation at both the local and international levels.

During the three-day event, DESC will spotlight a number of key initiatives, including the “Dubai Cyber Challenge”, an exclusive competitive simulation designed to enhance the cyber readiness of Dubai government entities, and the “School of Cyber Defense” CTF competition, which attracted registrations from over 300 university students, engaging them in technical challenges and hands-on training. These programs form a key part of DESC’s ongoing efforts to build a pipeline of skilled cybersecurity professionals equipped to navigate evolving digital threats.

H.E. Yousuf Hamad Al Shaibani, CEO of the Dubai Electronic Security Center, commented:
“DESC’s participation in GISEC Global 2025 reflects our steadfast commitment to securing Dubai’s digital future through proactive cybersecurity measures, innovation-driven initiatives, and an integrated ecosystem that fosters collaboration by building partnerships across public and private sectors. GISEC continues to serve as a dynamic platform where industry leaders, experts, and innovators come together to shape the future of cybersecurity.”

“GISEC 2025 provides a critical platform for strategic engagement with global cybersecurity innovators, allowing us to gain insights into emerging technologies and anticipate future threats. These interactions directly support our efforts to create forward-looking policies, develop advanced cyber solutions, and empower national talent to lead in this field. Through such initiatives, we continue to strengthen Dubai’s position as a global hub for cybersecurity excellence and digital innovation,” Al Shaibani added. 

DESC experts will also take part in high-level panel discussions addressing key challenges and emerging trends in the cybersecurity landscape. The Center will also formalize strategic partnerships and Memorandums of Understanding (MoUs), aimed at enhancing cross-sector collaboration and strengthening national efforts to secure the cyber space.

Visitors to GISEC Global 2025 are invited to explore DESC’s initiatives at Stand A80 in Hall 7, where DESC will showcase its latest projects, including future-ready cybersecurity guidelines and certification programs designed to keep pace with the evolving digital landscape and strengthen national capabilities. The stand will also serve as a unique opportunity for attendees to engage with DESC’s experts and explore opportunities for joint collaboration.

Secure your pass and learn more: GISEC GLOBAL | The World’s Leading Cyber Security Exhibition | 6 – 8 May 2025

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Dr. Katie Zippel Unveils Pioneering Research on Social Prescribing for Cancer Care

Published

on

NSW, Australia, 3rd May 2025 – Dr. Katie Zippel, a respected general practitioner and DPhil candidate at Oxford University, has introduced pioneering research that sheds light on the role of social prescribing in cancer care. Her latest study, soon to be published in a leading peer-reviewed journal, highlights how non-medical interventions can significantly enhance the well-being and long-term health outcomes of individuals living with cancer.

With both professional expertise and personal experience as a breast cancer survivor, Dr. Zippel brings a unique perspective to this research. Her study explores how integrating social support systems, lifestyle medicine, and community-driven initiatives into primary healthcare can improve the overall survivorship experience for cancer patients.

Social prescribing is a revolutionary healthcare approach that enables medical professionals to refer patients to non-medical services that support mental, emotional, and physical well-being. These services include arts-based therapies, exercise programmes, gardening projects, and community-based support groups.

Dr. Zippel’s research emphasizes that cancer treatment should go beyond conventional medicine and include holistic interventions that help patients cope with the psychological and social challenges that come with a cancer diagnosis. Her study presents strong evidence that structured social prescribing programmes significantly reduce stress, enhance emotional resilience, and improve overall quality of life.

Key Findings from the Research

Dr. Zippel’s study explores the tangible benefits of social prescribing by analysing patient experiences across various healthcare settings, including hospitals and community clinics. The research identifies several key findings that underscore the impact of these programmes:

  • Improved Mental Health: Patients engaged in social prescribing activities reported a 40% decrease in anxiety and depression symptoms compared to those receiving conventional treatment alone.
  • Stronger Social Connections: Over 70% of participants noted significant improvements in social engagement, reducing their sense of isolation.
  • Enhanced Physical Well-being: Patients who participated in prescribed exercise programmes experienced increased mobility, better energy levels, and overall improved health.
  • Better Treatment Adherence: Patients involved in non-medical support activities demonstrated greater commitment to their medical treatments and healthier lifestyle choices.
  • Long-Term Health Benefits: Individuals participating in social prescribing programmes were more likely to maintain a healthier lifestyle post-treatment, reducing the risk of cancer recurrence.

Bridging the Gap Between Medicine and Community Support

One of the core messages of Dr. Zippel’s research is the importance of bridging clinical medicine with community-based support systems. While medical treatments such as chemotherapy and radiation are essential in combating cancer, addressing the social determinants of health—such as loneliness, mental well-being, and financial stress—can play an equally crucial role in recovery.

A key innovation within Dr. Zippel’s work is her focus on narrative medicine, an approach that utilises storytelling to foster understanding, connection, and empowerment among cancer patients. By encouraging patients to share their experiences, she is helping create a more compassionate and patient-centred healthcare model.

A Global Call for Change in Cancer Survivorship Care

The findings from Dr. Zippel’s research have far-reaching implications for healthcare policies worldwide. As medical systems search for sustainable ways to improve cancer survivorship care, her work provides strong evidence supporting the expansion of social prescribing initiatives.

Going forward, Dr. Zippel aims to collaborate with global healthcare providers and policymakers to integrate social prescribing into mainstream medical practices, ensuring more patients have access to holistic, community-driven care.

A Personal Mission for Healthcare Innovation

For Dr. Zippel, this research is more than an academic pursuit—it is a deeply personal mission. As a breast cancer survivor, she understands firsthand the challenges of navigating treatment and recovery. Her lived experience has inspired her dedication to advancing equitable healthcare solutions, particularly for underserved and rural communities.

Beyond research, Dr. Zippel is actively engaged in primary healthcare delivery as part of a multidisciplinary team. Her work spans rural general practice, mental health support, and public health research, all aimed at bridging clinical medicine with social support systems to improve patient outcomes.

A Vision for Holistic Wellness

Through her online platform and research initiatives, Dr. Zippel explores the connection between daily habits, community engagement, and overall health. She shares insights on lifestyle medicine, disease prevention, and the power of human connection in healthcare. Her blog serves as an educational hub, featuring personal narratives, health education posts, and evidence-based research from leading medical journals.

To further her mission, Dr. Zippel plans to introduce video content and interactive discussions, allowing patients and healthcare professionals to engage with her research more directly. By blending storytelling with science, she hopes to make medical knowledge more accessible and relatable.

Join the Movement: Advocating for Social Prescribing

Dr. Katie Zippel’s groundbreaking research is leading a global shift in how cancer care is approached. She urges healthcare professionals, policymakers, and researchers to recognise the transformative impact of social prescribing in improving cancer survivorship.

By advocating for these innovative, community-centred healthcare solutions, Dr. Zippel is setting the stage for a future where cancer care is not only about medical treatment but also about fostering holistic healing and support networks that prioritise the well-being of every patient.

About Dr. Katie Zippel

Dr. Katie Zippel is a highly regarded general practitioner and a DPhil candidate at Oxford University, specialising in social prescribing for cancer care. Her work is rooted in evidence-based healthcare, lifestyle medicine, and patient-centred approaches, particularly in rural and remote areas. Through her research and advocacy, she continues to drive a global movement towards more compassionate and inclusive healthcare practices.

Media Contact

Organization: Dr. Katherine Zippel PTY LTD

Contact Person: Suzie Green

Website: https://katiezippel.com

Email: Send Email

Contact Number: +61474932326

Address:81-83 Campbell Street, Surry Hills, NSW, 2010

City: NSW

Country:Australia

Release id:27268

The post Dr. Katie Zippel Unveils Pioneering Research on Social Prescribing for Cancer Care appeared first on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Dr. Katie Zippel Unveils Pioneering Research on Social Prescribing for Cancer Care

Published

on

NSW, Australia, 3rd May 2025 – Dr. Katie Zippel, a respected general practitioner and DPhil candidate at Oxford University, has introduced pioneering research that sheds light on the role of social prescribing in cancer care. Her latest study, soon to be published in a leading peer-reviewed journal, highlights how non-medical interventions can significantly enhance the well-being and long-term health outcomes of individuals living with cancer.

With both professional expertise and personal experience as a breast cancer survivor, Dr. Zippel brings a unique perspective to this research. Her study explores how integrating social support systems, lifestyle medicine, and community-driven initiatives into primary healthcare can improve the overall survivorship experience for cancer patients.

Social prescribing is a revolutionary healthcare approach that enables medical professionals to refer patients to non-medical services that support mental, emotional, and physical well-being. These services include arts-based therapies, exercise programmes, gardening projects, and community-based support groups.

Dr. Zippel’s research emphasizes that cancer treatment should go beyond conventional medicine and include holistic interventions that help patients cope with the psychological and social challenges that come with a cancer diagnosis. Her study presents strong evidence that structured social prescribing programmes significantly reduce stress, enhance emotional resilience, and improve overall quality of life.

Key Findings from the Research

Dr. Zippel’s study explores the tangible benefits of social prescribing by analysing patient experiences across various healthcare settings, including hospitals and community clinics. The research identifies several key findings that underscore the impact of these programmes:

  • Improved Mental Health: Patients engaged in social prescribing activities reported a 40% decrease in anxiety and depression symptoms compared to those receiving conventional treatment alone.
  • Stronger Social Connections: Over 70% of participants noted significant improvements in social engagement, reducing their sense of isolation.
  • Enhanced Physical Well-being: Patients who participated in prescribed exercise programmes experienced increased mobility, better energy levels, and overall improved health.
  • Better Treatment Adherence: Patients involved in non-medical support activities demonstrated greater commitment to their medical treatments and healthier lifestyle choices.
  • Long-Term Health Benefits: Individuals participating in social prescribing programmes were more likely to maintain a healthier lifestyle post-treatment, reducing the risk of cancer recurrence.

Bridging the Gap Between Medicine and Community Support

One of the core messages of Dr. Zippel’s research is the importance of bridging clinical medicine with community-based support systems. While medical treatments such as chemotherapy and radiation are essential in combating cancer, addressing the social determinants of health—such as loneliness, mental well-being, and financial stress—can play an equally crucial role in recovery.

A key innovation within Dr. Zippel’s work is her focus on narrative medicine, an approach that utilises storytelling to foster understanding, connection, and empowerment among cancer patients. By encouraging patients to share their experiences, she is helping create a more compassionate and patient-centred healthcare model.

A Global Call for Change in Cancer Survivorship Care

The findings from Dr. Zippel’s research have far-reaching implications for healthcare policies worldwide. As medical systems search for sustainable ways to improve cancer survivorship care, her work provides strong evidence supporting the expansion of social prescribing initiatives.

Going forward, Dr. Zippel aims to collaborate with global healthcare providers and policymakers to integrate social prescribing into mainstream medical practices, ensuring more patients have access to holistic, community-driven care.

A Personal Mission for Healthcare Innovation

For Dr. Zippel, this research is more than an academic pursuit—it is a deeply personal mission. As a breast cancer survivor, she understands firsthand the challenges of navigating treatment and recovery. Her lived experience has inspired her dedication to advancing equitable healthcare solutions, particularly for underserved and rural communities.

Beyond research, Dr. Zippel is actively engaged in primary healthcare delivery as part of a multidisciplinary team. Her work spans rural general practice, mental health support, and public health research, all aimed at bridging clinical medicine with social support systems to improve patient outcomes.

A Vision for Holistic Wellness

Through her online platform and research initiatives, Dr. Zippel explores the connection between daily habits, community engagement, and overall health. She shares insights on lifestyle medicine, disease prevention, and the power of human connection in healthcare. Her blog serves as an educational hub, featuring personal narratives, health education posts, and evidence-based research from leading medical journals.

To further her mission, Dr. Zippel plans to introduce video content and interactive discussions, allowing patients and healthcare professionals to engage with her research more directly. By blending storytelling with science, she hopes to make medical knowledge more accessible and relatable.

Join the Movement: Advocating for Social Prescribing

Dr. Katie Zippel’s groundbreaking research is leading a global shift in how cancer care is approached. She urges healthcare professionals, policymakers, and researchers to recognise the transformative impact of social prescribing in improving cancer survivorship.

By advocating for these innovative, community-centred healthcare solutions, Dr. Zippel is setting the stage for a future where cancer care is not only about medical treatment but also about fostering holistic healing and support networks that prioritise the well-being of every patient.

About Dr. Katie Zippel

Dr. Katie Zippel is a highly regarded general practitioner and a DPhil candidate at Oxford University, specialising in social prescribing for cancer care. Her work is rooted in evidence-based healthcare, lifestyle medicine, and patient-centred approaches, particularly in rural and remote areas. Through her research and advocacy, she continues to drive a global movement towards more compassionate and inclusive healthcare practices.

Media Contact

Organization: Dr. Katherine Zippel PTY LTD

Contact Person: Suzie Green

Website: https://katiezippel.com

Email: Send Email

Contact Number: +61474932326

Address:81-83 Campbell Street, Surry Hills, NSW, 2010

City: NSW

Country:Australia

Release id:27268

The post Dr. Katie Zippel Unveils Pioneering Research on Social Prescribing for Cancer Care appeared first on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST